These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27346432)

  • 1. Design and in vitro characterization of ivermectin nanocrystals liquid formulation based on a top-down approach.
    Starkloff WJ; Bucalá V; Palma SD; Gonzalez Vidal NL
    Pharm Dev Technol; 2017 Sep; 22(6):809-817. PubMed ID: 27346432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of amorphous indomethacin nanoparticles by aqueous wet bead milling and in situ measurement of their increased saturation solubility.
    Colombo M; Minussi C; Orthmann S; Staufenbiel S; Bodmeier R
    Eur J Pharm Biopharm; 2018 Apr; 125():159-168. PubMed ID: 29371046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation.
    Patel GV; Patel VB; Pathak A; Rajput SJ
    Drug Dev Ind Pharm; 2014 Jan; 40(1):80-91. PubMed ID: 23323843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissolution study of nanocrystal powders of a poorly soluble drug by UV imaging and channel flow methods.
    Sarnes A; Østergaard J; Jensen SS; Aaltonen J; Rantanen J; Hirvonen J; Peltonen L
    Eur J Pharm Sci; 2013 Nov; 50(3-4):511-9. PubMed ID: 23999036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Process and Formulation Parameters on the Fabrication of Efavirenz Nanosuspension to Improve Drug Solubility and Dissolution.
    Rashed M; Dadashzadeh S; Bolourchian N
    Iran J Pharm Res; 2022 Dec; 21(1):e129409. PubMed ID: 36942076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanosizing of a poorly soluble drug: technique optimization, factorial analysis, and pharmacokinetic study in healthy human volunteers.
    Elsayed I; Abdelbary AA; Elshafeey AH
    Int J Nanomedicine; 2014; 9():2943-53. PubMed ID: 24971006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Praziquantel systems with improved dissolution rate obtained by high pressure homogenization.
    Gonzalez MA; Ramírez Rigo MV; Gonzalez Vidal NL
    Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():28-35. PubMed ID: 30274060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanosizing of valsartan by high pressure homogenization to produce dissolution enhanced nanosuspension: pharmacokinetics and pharmacodyanamic study.
    Gora S; Mustafa G; Sahni JK; Ali J; Baboota S
    Drug Deliv; 2016; 23(3):940-50. PubMed ID: 24937379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution enhancement and in vitro performance of clarithromycin nanocrystals produced by precipitation-lyophilization-homogenization method.
    Morakul B; Suksiriworapong J; Chomnawang MT; Langguth P; Junyaprasert VB
    Eur J Pharm Biopharm; 2014 Nov; 88(3):886-96. PubMed ID: 25201298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of uncharged and charged stabilizers on in vitro drug performances of clarithromycin nanocrystals.
    Soisuwan S; Teeranachaideekul V; Wongrakpanich A; Langguth P; Junyaprasert VB
    Eur J Pharm Biopharm; 2019 Apr; 137():68-76. PubMed ID: 30769087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
    Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of pluronic nanosuspensions loading a novel insoluble anticancer drug both in vitro and in vivo.
    Tang XJ; Fu YH; Meng QH; Li LM; Ying XY; Han M; He QJ; Yang B; Zeng S; Hu YZ; Sheng XX; Gao JQ
    Int J Pharm; 2013 Nov; 456(1):243-50. PubMed ID: 23928148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of oral lyophilisates containing meloxicam nanocrystals using QbD approach.
    Iurian S; Bogdan C; Tomuță I; Szabó-Révész P; Chvatal A; Leucuța SE; Moldovan M; Ambrus R
    Eur J Pharm Sci; 2017 Jun; 104():356-365. PubMed ID: 28435075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of media milling and microfluidization methods for engineering of nanocrystals: a case study.
    Chogale M; Gite S; Patravale V
    Drug Dev Ind Pharm; 2020 Nov; 46(11):1763-1775. PubMed ID: 32912040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Optimization, and Evaluation of Lurasidone Hydrochloride Nanocrystals.
    Shah S; Parmar B; Soniwala M; Chavda J
    AAPS PharmSciTech; 2016 Oct; 17(5):1150-8. PubMed ID: 26586537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
    Sawant KK; Patel MH; Patel K
    Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation of dried lignans nanosuspension with high redispersibility to enhance stability, dissolution, and oral bioavailability.
    Shen G; Cheng L; Wang LQ; Zhang LH; Shen BD; Liao WB; Li JJ; Zheng J; Xu R; Yuan HL
    Chin J Nat Med; 2016 Oct; 14(10):757-768. PubMed ID: 28236405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aceclofenac nanocrystals with enhanced in vitro, in vivo performance: formulation optimization, characterization, analgesic and acute toxicity studies.
    Rahim H; Sadiq A; Khan S; Khan MA; Shah SMH; Hussain Z; Ullah R; Shahat AA; Ibrahim K
    Drug Des Devel Ther; 2017; 11():2443-2452. PubMed ID: 28860715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabrication of multicomponent amorphous bufadienolides nanosuspension with wet milling improves dissolution and stability.
    Zuo W; Qu W; Li N; Yu R; Hou Y; Liu Y; Gou G; Yang J
    Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1513-1522. PubMed ID: 28906144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.